RxDoctor Payments Data

Urja Shah

Foot & Ankle Surgery · Chandler, AZNPI 1154771129

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (60.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 47.4% of the total. Reporting peaked in 2022 at $6,401 and has fallen 97.0% since, to $192 in 2025.

$19,943in general payments, 2019–2025

Across 173 payments — averaging $115.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$9K
  • Arthrex$5K
  • Treace Medical Concepts, Inc.$2K
  • Amgen$501
  • Smith+Nephew$483
  • Nevro Corp.$428
  • plus $2K from 32 others

What the payments were for

  • Speaking & faculty fees$1251%
  • Travel & lodging$3,26216%
  • Food & beverage$4,59823%
  • Education$11,95860%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,943 in reported general payments places this provider in the 85th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$99,142
Medicare patients
237
Services billed
1,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl17$475
Clotrimazole11$124
Doxycycline Hyclate13$121

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →